Physician
GL Pediatrics INC
GL Pediatrics INC was paid $1.13M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 14% of everything it billed.
33Billing provider infoGL PEDIATRICS INC
LOWELL, MA 01852
LOWELL, MA 01852
33aNPI1003988346assigned 11/14/2006
33bProvider typePediatrics Physician
28Total paid$1.13M
24GClaims71,401
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#69 of 1,273
Median peer was paid$24K
This provider vs. median47×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,307 | $195K | |
| 2019 | 925 | $21K | |
| 2020 | 725 | $12K | |
| 2021 | 396 | $8K | |
| 2022 | 841 | $18K | |
| 2023 | 27,028 | $337K | |
| 2024incomplete | 35,179 | $538K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 16,503 | 15,852 | $156K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 6,002 | 5,760 | $151K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 11% | 4,397 | 4,348 | $130K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 11% | 1,640 | 1,623 | $129K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 8.8% | 641 | 463 | $99K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.0% | 1,683 | 1,661 | $79K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 5.2% | 306 | 292 | $59K |
| 96127 | 3.9% | 4,405 | 4,394 | $44K | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 3.6% | 5,594 | 5,577 | $41K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.0% | 3,339 | 3,294 | $34K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.8% | 260 | 219 | $32K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.5% | 1,328 | 1,307 | $28K |
44 more codes
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.1% | 5,787 | $24K |
| 90785 | 1.4% | 702 | $16K | |
| 92558 | 1.2% | 1,807 | $14K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 1,738 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 1,005 | $12K |
| 83655 | <1% | 1,002 | $11K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,909 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 623 | $8K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,134 | $8K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,557 | $6K |
| 90461 | <1% | 108 | $4K | |
| 92587 | <1% | 226 | $4K | |
| 87081 | <1% | 408 | $3K | |
| 99188 | <1% | 90 | $2K | |
| 99177 | <1% | 563 | $2K | |
| 99381 | <1% | 25 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 72 | $1K |
| 94760 | <1% | 1,054 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 31 | $959.45 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 28 | $866.60 |
| 87634 | <1% | 13 | $804.96 | |
| 81003 | <1% | 379 | $718.74 | |
| 90651 | <1% | 182 | $586.32 | |
| 90686 | <1% | 641 | $581.52 | |
| 90661 | <1% | 193 | $532.97 | |
| 99173 | <1% | 459 | $454.08 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 404 | $254.63 |
| 99051 | <1% | 12 | $182.16 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 43 | $108.65 |
| 90656 | <1% | 693 | $17.69 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 25 | $13.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 29 | $8.35 |
| 99072 | 0% | 46 | $0.00 | |
| 90715 | 0% | 13 | $0.00 | |
| 90670 | 0% | 32 | $0.00 | |
| 90633 | 0% | 153 | $0.00 | |
| 90707 | 0% | 29 | $0.00 | |
| 90677 | 0% | 533 | $0.00 | |
| 90619 | 0% | 214 | $0.00 | |
| 36416 | 0% | 19 | $0.00 | |
| 90698 | 0% | 112 | $0.00 | |
| 90680 | 0% | 163 | $0.00 | |
| 90697 | 0% | 33 | $0.00 | |
| 90716 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOUSIOS, PETER (PRACTICE ADMINISTRATOR)